What is Amass?
Amass operates at the sophisticated nexus of the beverage and wellness industries, curating a portfolio that emphasizes clean, plant-based ingredients. By bridging the gap between social rituals and daily self-care, the company has carved out a distinct niche. Its product architecture spans from complex botanic spirits, such as Dry Gin and Botanic Vodka, to functional non-alcoholic alternatives like Riverine. Furthermore, the brand extends its commitment to botanical integrity into the personal care sector, offering artisanal soaps, candles, and sanitizers that appeal to the modern, health-conscious consumer who prioritizes ingredient transparency and aesthetic quality.
How much funding has Amass raised?
Amass has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Amass
PPP
Public-Private Partnership
What's next for Amass?
Following this major strategic investment, Amass is expected to leverage its capital to scale production capabilities and broaden its distribution footprint. The late-stage nature of this funding suggests a focus on operational efficiency and market dominance within the premium lifestyle segment. Future initiatives will likely involve deepening the brand's presence in key retail channels and potentially diversifying its product pipeline to capture a larger share of the growing sober-curious and wellness-oriented demographics. As the company matures, the emphasis will remain on maintaining the premium positioning of its botanical offerings while navigating the competitive landscape of the global consumer goods market.
See full Amass company page
